Skip to main content
Premium Trial:

Request an Annual Quote

Stilla Technologies: Philippe Mourere, Rémi Dangla

Stilla Technologies has appointed Philippe Mourere as CEO, to replace founder and CEO Rémi Dangla. Mourere has 25 years of diagnostics executive experience at firms such as HalioDx, Ultivue, Cell Signaling Technology, PerkinElmer, and Caliper Life Sciences. Dangla has been appointed Stilla's chief technology officer and remains a member of the board of directors.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.